Stand out for this role — generate a tailored resume and cover letter in about a minute.
Scorpion Therapeutics seeks a Head of Quantitative Pharmacology & Pharmacometrics (QP2) to lead oncology drug development strategy, integrating modeling to inform dosing, safety, efficacy, and portfolio decisions.
The role requires a PhD with 15+ years in drug development, including 5+ in oncology, with expertise across modalities and leadership of interdisciplinary teams. Hybrid work with flexible location is offered.
Head of Quantitative Pharmacology & Pharmacometrics (QP2) to lead oncology drug development strategy, integrating advanced analytics and modeling to inform dosing, safety, efficacy, and portfolio decisions.
establish enterprise QP2 strategy, oversee team, shape program design, guide regulatory interactions, and develop a modern quantitative operating model for oncology.
Ph.D. with 15+ years in drug development, including 5+ years in oncology, with expertise across modalities like ADCs, small molecules, TCEs, and biologics.
Demonstrated impact in model-informed drug development, regulatory submissions, and leadership of interdisciplinary teams.
High-Value: oncology, multiple modalities, regulatory filings (NDA/MAA), advanced modeling techniques, application of AI/ML, and translational sciences.
hybrid with flexible location; no specific travel noted.